Human Anti-CD5 Antibody Product Attributes
CD5 Previously Observed Antibody Staining Patterns
Observed Antibody Staining Data By Tissue Type:
Variations in CD5 antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in cells in the white pulp in spleen and non-germinal center cells in the lymph node and tonsil. More moderate antibody staining intensity was present in cells in the white pulp in spleen and non-germinal center cells in the lymph node and tonsil. Low, but measureable presence of CD5 could be seen in. We were unable to detect CD5 in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.
CD5 General Information | |
---|---|
Alternate Names | |
CD5, Cluster of Differentiation 5 | |
Molecular Weight | |
67kDa | |
Chromosomal Location | |
11q12.2 | |
Curated Database and Bioinformatic Data | |
Gene Symbol | CD5 |
Entrez Gene ID | 921 |
Ensemble Gene ID | ENSG00000110448 |
RefSeq Protein Accession(s) | NP_001333385, NP_055022 |
RefSeq mRNA Accession(s) | NM_014207, NM_001346456 |
RefSeq Genomic Accession(s) | NC_018922, NC_000011, |
UniProt ID(s) | P06127 |
UniGene ID(s) | P06127 |
HGNC ID(s) | 1685 |
Cosmic ID(s) | CD5 |
KEGG Gene ID(s) | hsa:921 |
PharmGKB ID(s) | PA26224 |
General Description of CD5. | |
Recognizes a 67kDa transmembrane protein, which is identified as CD5. The CD5 antigen is found on 95% of thymocytes, 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma,, a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Anti-CD5 detection is diagnostic in CLL/SLL within a panel of other B-cell markers, especially one that includes anti-CD23. Anti-CD5 is also very useful in differentiating among mature small lymphoid cell malignancies. In addition, anti-CD5 can be used in distinguishing thymic carcinoma (+) from thymoma (-). Anti-CD5 does not react with granulocytes or monocytes. |
There are no reviews yet.